Attia Seba Hassan, Elshazly Shimaa Mustafa, Abdelaal Mahmoud Mohamed, Soliman Eman
Clinical Pharmacology Department, Faculty of Medicine, Zagazig University, Egypt.
Pharmacology and Toxicology Department, Faculty of Pharmacy, Zagazig University, Egypt.
Saudi Pharm J. 2022 Sep;30(9):1252-1261. doi: 10.1016/j.jsps.2022.06.026. Epub 2022 Jul 1.
Methotrexate (MTX) is an immunosuppressant used for the treatment of cancer and autoimmune diseases. MTX has a major adverse effect, acute kidney injury, which limits its use. Mangiferin (MF) is a natural bioactive xanthonoid used as a traditional herbal supplement to boost the immune system due to its potent anti-inflammatory and antioxidant activity. The present study evaluates the protective effect of MF against MTX-induced kidney damage. Male Wistar rats received MTX to induce nephrotoxicity or were pretreated with MF for 10 constitutive days before MTX administration. MF dose-dependently improved renal functions of MTX-treated rats and this activity was correlated with increased renal expression of PPARγ, a well-known transcriptional regulator of the immune response. Pretreating rats with PPARγ inhibitor, BADGE, reduced the reno-protective activity of MF. Furthermore, MF treatment significantly reduced MTX-induced upregulation of the pro-inflammatory (NFκB, interleukin-1ß, TNF-α, and COX-2), oxidative stress (Nrf-2, hemoxygenase-1, glutathione, and malondialdehyde), and nitrosative stress (nitric oxide and iNOS) markers in the kidney. Importantly, BADGE treatment significantly reduced the anti-inflammatory and antioxidant activity of MF. Therefore, our data suggest that the reno-protective effect of MF against MTX-induced nephrotoxicity is due to inhibition of inflammation and oxidative stress in a PPAR-γ-dependent manner.
甲氨蝶呤(MTX)是一种用于治疗癌症和自身免疫性疾病的免疫抑制剂。MTX有一个主要的不良反应,即急性肾损伤,这限制了它的使用。芒果苷(MF)是一种天然的生物活性呫吨酮,由于其强大的抗炎和抗氧化活性,被用作传统的草药补充剂来增强免疫系统。本研究评估了MF对MTX诱导的肾损伤的保护作用。雄性Wistar大鼠接受MTX以诱导肾毒性,或者在给予MTX前连续10天用MF进行预处理。MF剂量依赖性地改善了MTX处理大鼠的肾功能,并且这种活性与肾脏中PPARγ(一种众所周知的免疫反应转录调节因子)表达的增加相关。用PPARγ抑制剂BADGE预处理大鼠降低了MF的肾保护活性。此外,MF治疗显著降低了MTX诱导的肾脏中促炎(NFκB、白细胞介素-1β、肿瘤坏死因子-α和环氧化酶-2)、氧化应激(Nrf-2、血红素加氧酶-1、谷胱甘肽和丙二醛)以及亚硝化应激(一氧化氮和诱导型一氧化氮合酶)标志物的上调。重要的是,BADGE治疗显著降低了MF抗炎和抗氧化活性。因此,我们的数据表明MF对MTX诱导的肾毒性的肾保护作用是由于以PPAR-γ依赖性方式抑制炎症和氧化应激。
Immunopharmacol Immunotoxicol. 2014-2-13
Pharmaceuticals (Basel). 2022-12-21
Curr Issues Mol Biol. 2021-10-24
Food Chem Toxicol. 2021-3
Int J Mol Sci. 2020-7-6
Int J Nephrol. 2020-2-25
Toxicol Appl Pharmacol. 2018-10-26